Dyadic International (DYAI) Receivables (2017 - 2026)
Dyadic International's (DYAI) quarterly Receivables came in at $996464.0 in Q1 2026, up 306.83% year-over-year from $244932.0 in Q1 2025, and down 8.61% quarter-over-quarter from $1.1 million in Q4 2025.
Analysis
Dyadic International (DYAI) Receivables (2017 - 2026) Analysis & Trends
Dyadic International has disclosed Receivables across 10 years of filings, most recently posting $996464.0 for Q1 2026.
- In Q1 2026, Receivables rose 306.83% year-over-year to $996464.0; the TTM figure through Mar 2026 stood at $996464.0 (up 306.83% YoY), while the FY2025 annual figure was $1.1 million, up 317.3% from the prior year.
- Receivables came in at $996464.0 for Q1 2026 at Dyadic International, down from $1.1 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $557.0 million in Q1 2022 to a low of $179285.0 in Q4 2022.
- Average Receivables over 5 years is $33.3 million, with a median of $427700.0 recorded in 2023.
- Year-over-year, Receivables jumped 102644.74% in 2022 and sank 99.86% in 2023.
- Over 5 years, Receivables stood at $179285.0 in 2022, then increased by 24.43% to $223083.0 in 2023, then grew by 17.12% to $261275.0 in 2024, then surged by 317.3% to $1.1 million in 2025, then retreated by 8.61% to $996464.0 in 2026.
- Per Business Quant data, the three most recent Receivables figures were $996464.0 in Q1 2026, $1.1 million in Q4 2025, and $916574.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 10.23 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 5.90 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 2.13 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 6.57 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.93 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 160.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 912.74 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 1.89 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | - |
| 10 | Dyadic International | 17.78 Mn | 9.82 Mn | - | 996,464.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 996,464.00 |
| Dec 31, 2025 | 1.09 Mn |
| Sep 30, 2025 | 916,574.00 |
| Jun 30, 2025 | 715,317.00 |
| Mar 31, 2025 | 244,932.00 |
| Dec 31, 2024 | 261,275.00 |
| Sep 30, 2024 | 393,769.00 |
| Jun 30, 2024 | 277,966.00 |
| Mar 31, 2024 | 261,365.00 |
| Dec 31, 2023 | 223,083.00 |
| Sep 30, 2023 | 427,700.00 |
| Jun 30, 2023 | 803,650.00 |
| Mar 31, 2023 | 784,176.00 |
| Dec 31, 2022 | 179,285.00 |
| Sep 30, 2022 | 279,241.00 |
| Jun 30, 2022 | 1.19 Mn |
| Mar 31, 2022 | 557.05 Mn |
| Dec 31, 2021 | 251,375.00 |
| Sep 30, 2021 | 254,793.00 |
| Jun 30, 2021 | 454,748.00 |